Yellow fever: Experimental monoclonal antibody shows success in early-stage clinical trials in Singapore

Yellow fever, a hemorrhagic disease that is common in South America and sub-Saharan Africa, infects about 200,000 people per year and causes an estimated 30,000 deaths. While there is a vaccine for yellow fever, it can't be given to some people because of the risk of side effects, and there are no approved treatments for [...]

The post Yellow fever: Experimental monoclonal antibody shows success in early-stage clinical trials in Singapore appeared first on Outbreak News Today.